Latest filing published 12 May 2023 for G1 Therapeutics, Inc..
Insider track record
No signal scores available.
John Umstead V: trading record in brief
John Umstead V is a declared insider of G1 Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 15 March 2023 to 10 May 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 12 May 2023, reports a share grant in G1 Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John Umstead V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares0Common StockSEC:0001562180-23-004096:0
- 50,000 shares0Common StockSEC:0001562180-23-002913:0
2 of 2 declarations